×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ACLX – arcellx, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ACLX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/8
01:20 pm
aclx
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $130.00 price target on the stock.
Medium
Report
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc.. They now have a $130.00 price target on the stock.
12/8
08:07 am
aclx
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $105.00 price target on the stock.
Medium
Report
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $105.00 price target on the stock.
12/6
02:24 pm
aclx
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma [Yahoo! Finance]
Medium
Report
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma [Yahoo! Finance]
12/6
02:24 pm
aclx
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel's Opportunity in Relapsed or Refractory Multiple Myeloma [Yahoo! Finance]
Medium
Report
Kite Announces New Data for Pivotal iMMagine-1 Study at ASH 2025, Highlighting Anito-cel's Opportunity in Relapsed or Refractory Multiple Myeloma [Yahoo! Finance]
12/6
02:00 pm
aclx
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
Medium
Report
Arcellx Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
11/30
05:51 am
aclx
CAR-Therapy Keeps Analyst Confidence in Arcellx (ACLX) High Ahead of the ASH Meeting [Yahoo! Finance]
Medium
Report
CAR-Therapy Keeps Analyst Confidence in Arcellx (ACLX) High Ahead of the ASH Meeting [Yahoo! Finance]
11/24
03:08 pm
aclx
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
11/24
03:08 pm
aclx
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Guggenheim.
Low
Report
Arcellx (NASDAQ:ACLX) had its "buy" rating reaffirmed by analysts at Guggenheim.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
12/8
04:26 pm
aclx
Form 8-K Arcellx, Inc. For: Dec 06
Medium
Report
Form 8-K Arcellx, Inc. For: Dec 06
12/5
12:52 pm
aclx
Form SCHEDULE 13G/A Arcellx, Inc. Filed by: T. Rowe Price Investment Management, Inc.
Low
Report
Form SCHEDULE 13G/A Arcellx, Inc. Filed by: T. Rowe Price Investment Management, Inc.
11/17
07:16 pm
aclx
Form 4 Arcellx, Inc. For: Nov 17 Filed by: Heery Christopher
Low
Report
Form 4 Arcellx, Inc. For: Nov 17 Filed by: Heery Christopher
11/5
04:11 pm
aclx
Form 10-Q Arcellx, Inc. For: Sep 30
Low
Report
Form 10-Q Arcellx, Inc. For: Sep 30
11/5
04:04 pm
aclx
Form 8-K Arcellx, Inc. For: Nov 05
Low
Report
Form 8-K Arcellx, Inc. For: Nov 05
11/5
11:27 am
aclx
Form SCHEDULE 13G/A Arcellx, Inc. Filed by: FMR LLC
Low
Report
Form SCHEDULE 13G/A Arcellx, Inc. Filed by: FMR LLC
10/15
07:28 pm
aclx
Form 4 Arcellx, Inc. For: Oct 15 Filed by: Gilson Michelle
Medium
Report
Form 4 Arcellx, Inc. For: Oct 15 Filed by: Gilson Michelle
10/15
04:38 pm
aclx
Form 144 Arcellx, Inc. Filed by: Gilson Michelle
Low
Report
Form 144 Arcellx, Inc. Filed by: Gilson Michelle
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: